LENZ Therapeutics, Inc. (LENZ): Total Assets
$305.88M
As of 2025-12-31
$236.60M
As of 2026-06-30
-1.7%
3-year compound annual growth
+68.4%
5-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $305.88M | +42.1% | 2026-03-24, Balance as of period end |
| 2024-12-31 | $215.30M | +205.9% | 2026-03-24, Balance as of period end |
| 2023-12-31 | $70.38M | -78.1% | 2025-03-19, Balance as of period end |
| 2022-12-31 | $321.90M | -19.9% | 2024-02-27, Balance as of period end |
| 2021-12-31 | $401.99M | n/m | 2023-03-20, Balance as of period end |
| 2020-12-31 | $22.56M | n/a | 2022-03-21, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| LENZ Therapeutics, Inc. (LENZ) | 2025-12-31 | $305.88M | +42.1% |
| Alector, Inc. (ALEC) | 2025-12-31 | $293.24M | -37.4% |
| Pelthos Therapeutics Inc. (PTHS) | 2025-12-31 | $130.40M | n/m |
| Relay Therapeutics, Inc. (RLAY) | 2025-12-31 | $621.33M | -28.7% |
| Lineage Cell Therapeutics, Inc. (LCTX) | 2025-12-31 | $112.58M | -0.6% |
| Metagenomi Therapeutics, Inc. (MGX) | 2025-12-31 | $221.10M | -31.9% |
| Scilex Holding Co (SCLX) | 2025-12-31 | $364.98M | +292.7% |
| Caribou Biosciences, Inc. (CRBU) | 2025-12-31 | $175.37M | -44.0% |
| Precision Biosciences Inc (DTIL) | 2025-12-31 | $154.42M | +13.2% |
Compare LENZ, ALEC, PTHS, RLAY side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗